Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty

Dean J. Kereiakes, Neal S. Kleiman, John Ambrose, Marc Cohen, Samuel Rodriguez, Theresa Palabrica, Howard C. Herrmann, Joseph M. Sutton, W. Douglas Weaver, Donna B. McKee, Virginia Fitzpatrick, Frederic L. Sax

Research output: Contribution to journal › Article › peer-review

210 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty'. Together they form a unique fingerprint.

Medicine & Life Sciences